Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA DR. REDDYS LAB AUROBINDO PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 12.3 24.1 51.2% View Chart
P/BV x 1.3 3.7 36.3% View Chart
Dividend Yield % 1.6 0.7 225.6%  

Financials

 AUROBINDO PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
DR. REDDYS LAB
Mar-22
AUROBINDO PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0645,614 18.9%   
Low Rs5843,655 16.0%   
Sales per share (Unadj.) Rs400.31,294.6 30.9%  
Earnings per share (Unadj.) Rs45.7126.9 36.0%  
Cash flow per share (Unadj.) Rs64.9196.9 33.0%  
Dividends per share (Unadj.) Rs9.0030.00 30.0%  
Avg Dividend yield %1.10.6 168.7%  
Book value per share (Unadj.) Rs419.41,145.8 36.6%  
Shares outstanding (eoy) m585.94166.43 352.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.13.6 57.5%   
Avg P/E ratio x18.036.5 49.4%  
P/CF ratio (eoy) x12.723.5 53.9%  
Price / Book Value ratio x2.04.0 48.6%  
Dividend payout %19.723.6 83.3%   
Avg Mkt Cap Rs m482,799771,272 62.6%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50938,858 88.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555215,452 108.9%  
Other income Rs m3,2264,847 66.6%   
Total revenues Rs m237,781220,299 107.9%   
Gross profit Rs m42,56637,674 113.0%  
Depreciation Rs m11,26511,652 96.7%   
Interest Rs m486958 50.8%   
Profit before tax Rs m34,04029,911 113.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2568,789 82.6%   
Profit after tax Rs m26,78421,122 126.8%  
Gross profit margin %18.117.5 103.8%  
Effective tax rate %21.329.4 72.5%   
Net profit margin %11.49.8 116.5%  
BALANCE SHEET DATA
Current assets Rs m181,227177,880 101.9%   
Current liabilities Rs m81,56097,658 83.5%   
Net working cap to sales %42.537.2 114.1%  
Current ratio x2.21.8 122.0%  
Inventory Days Days2556 45.0%  
Debtors Days Days62113 55.2%  
Net fixed assets Rs m155,104106,819 145.2%   
Share capital Rs m586832 70.4%   
"Free" reserves Rs m245,174189,859 129.1%   
Net worth Rs m245,760190,691 128.9%   
Long term debt Rs m2,4925,746 43.4%   
Total assets Rs m336,331284,699 118.1%  
Interest coverage x71.032.2 220.3%   
Debt to equity ratio x00 33.7%  
Sales to assets ratio x0.70.8 92.2%   
Return on assets %8.17.8 104.5%  
Return on equity %10.911.1 98.4%  
Return on capital %13.915.7 88.5%  
Exports to sales %31.147.1 65.9%   
Imports to sales %11.918.8 63.6%   
Exports (fob) Rs m72,862101,544 71.8%   
Imports (cif) Rs m27,96540,401 69.2%   
Fx inflow Rs m77,245101,544 76.1%   
Fx outflow Rs m31,52440,401 78.0%   
Net fx Rs m45,72161,143 74.8%   
CASH FLOW
From Operations Rs m50,16528,108 178.5%  
From Investments Rs m-32,116-26,387 121.7%  
From Financial Activity Rs m-29,693-2,422 1,226.0%  
Net Cashflow Rs m-11,67432 -36,481.3%  

Share Holding

Indian Promoters % 48.8 26.7 182.6%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 51.1 74.5%  
FIIs % 20.7 25.9 80.1%  
ADR/GDR % 0.0 10.4 -  
Free float % 48.2 62.9 76.6%  
Shareholders   359,684 255,300 140.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    CIPLA    ZYDUS LIFESCIENCES    LUPIN    SANOFI INDIA    



Today's Market

Indian Share Markets End Flat; IT and FMCG Stocks Witness Selling(Closing)

Indian share markets traded in a rangebound manner throughout the day to end on a flat note.